Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.
MER Indicator |
MER description |
Target Fiscal Year |
Target |
C2.1.D |
By Age: <15 |
2015 |
1,247 |
C2.1.D |
By Age: <15 |
2015 |
5,248 |
C2.1.D |
By Age: 15+ |
2015 |
14,740 |
C2.1.D |
By Age: 15+ |
2015 |
62,909 |
C2.1.D |
By Age/Sex: <15 Female |
2015 |
719 |
C2.1.D |
By Age/Sex: <15 Female |
2015 |
2,873 |
C2.1.D |
By Age/Sex: <15 Male |
2015 |
527 |
C2.1.D |
By Age/Sex: <15 Male |
2015 |
2,511 |
C2.1.D |
By Age/Sex: 15+ Female |
2015 |
9,640 |
C2.1.D |
By Age/Sex: 15+ Female |
2015 |
42,495 |
C2.1.D |
By Age/Sex: 15+ Male |
2015 |
5,101 |
C2.1.D |
By Age/Sex: 15+ Male |
2015 |
22,027 |
C2.1.D |
By Sex: Female |
2015 |
10,359 |
C2.1.D |
By Sex: Female |
2015 |
44,302 |
C2.1.D |
By Sex: Male |
2015 |
5,627 |
C2.1.D |
By Sex: Male |
2015 |
23,855 |
C2.1.D |
Number of HIV-positive individuals receiving a minimum of one clinical service |
2015 |
15,987 |
C2.1.D |
Number of HIV-positive individuals receiving a minimum of one clinical service |
2015 |
69,906 |
C2.1.D |
Sum of Age disaggregates |
2015 |
15,987 |
C2.1.D |
Sum of Age disaggregates |
2015 |
68,157 |
C2.1.D |
Sum of Age/Sex disaggregates |
2015 |
15,987 |
C2.1.D |
Sum of Age/Sex disaggregates |
2015 |
69,906 |
C2.1.D |
Sum of Sex disaggregates |
2015 |
15,986 |
C2.1.D |
Sum of Sex disaggregates |
2015 |
68,157 |
C2.1.D_NGI |
By Age: <15 |
2015 |
6,479 |
C2.1.D_NGI |
By Age: 15+ |
2015 |
77,664 |
C2.1.D_NGI |
By Age/Sex: <15 Female |
2015 |
3,449 |
C2.1.D_NGI |
By Age/Sex: <15 Male |
2015 |
3,029 |
C2.1.D_NGI |
By Age/Sex: 15+ Female |
2015 |
51,160 |
C2.1.D_NGI |
By Age/Sex: 15+ Male |
2015 |
26,505 |
C2.1.D_NGI |
By Sex: Female |
2015 |
54,693 |
C2.1.D_NGI |
By Sex: Male |
2015 |
29,450 |
C2.1.D_NGI |
Number of HIV-positive individuals receiving a minimum of one clinical service |
2015 |
84,143 |
C2.1.D_NGI |
Sum of Age disaggregates |
2015 |
84,143 |
C2.1.D_NGI |
Sum of Age/Sex disaggregates |
2015 |
84,143 |
C2.1.D_NGI |
Sum of Sex disaggregates |
2015 |
84,143 |
C2.4.D |
Number of HIV-positive individuals receiving a minimum of one clinical service |
2015 |
69,906 |
C2.4.D |
Number of HIV-positive patients who were screened for TB in HIV care or treatment setting |
2015 |
75,730 |
CARE_CURR |
Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female |
2015 |
708 |
CARE_CURR |
Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female |
2015 |
3,020 |
CARE_CURR |
Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male |
2015 |
519 |
CARE_CURR |
Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male |
2015 |
2,215 |
CARE_CURR |
Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female |
2015 |
9,495 |
CARE_CURR |
Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female |
2015 |
40,469 |
CARE_CURR |
Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male |
2015 |
5,021 |
CARE_CURR |
Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male |
2015 |
21,410 |
CARE_CURR |
Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load |
2015 |
15,743 |
CARE_CURR |
Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load |
2015 |
67,114 |
CARE_CURR |
Sum of Aggregated Age/Sex disaggregates |
2015 |
15,743 |
CARE_CURR |
Sum of Aggregated Age/Sex disaggregates |
2015 |
67,114 |
CARE_NEW |
Aggregated Age/sex: <15 Female |
2015 |
782 |
CARE_NEW |
Aggregated Age/sex: <15 Male |
2015 |
839 |
CARE_NEW |
Aggregated Age/sex: 15+ Female |
2015 |
11,602 |
CARE_NEW |
Aggregated Age/sex: 15+ Male |
2015 |
5,859 |
CARE_NEW |
Number of HIV-infected adults and children newly enrolled in clinical care during the reporting period and received at least one of the following at enrollment: clinical assessment (WHO staging) OR CD4 count OR viral load |
2015 |
19,086 |
CARE_NEW |
Sum of Aggregated Age/sex disaggregates |
2015 |
19,082 |
FN_SITE |
By site support type: Technical Assistance-only (TA): Number of PEPFAR-supported sites achieving 90% nutrition assessments that result in accurate categorization of malnutrition |
2015 |
142 |
FN_SITE |
By site support type: Technical Assistance-only (TA): Total number of PEPFAR-supported sites providing nutrition assessment, counseling and support (NACS) services |
2015 |
142 |
FN_SITE |
Number of PEPFAR-supported sites achieving 90% nutrition assessments that result in accurate categorization of malnutrition |
2015 |
142 |
FN_SITE |
Sum of Numerator Support Type disaggregates |
2015 |
142 |
FN_SITE |
Total number of PEPFAR-supported sites providing nutrition assessment, counseling and support (NACS) services |
2015 |
189 |
FN_SITE_den |
Sum of Denominator Support Type disaggregates |
2015 |
142 |
FPINT_SITE |
By site support type: Direct Service Delivery (DSD): Number of service delivery points supported by PEPFAR for HIV services that are directly providing integrated voluntary family planning services |
2015 |
221 |
FPINT_SITE |
By site support type: Direct Service Delivery (DSD): Total number of PEPFAR-supported HIV service delivery points |
2015 |
221 |
FPINT_SITE |
Number of service delivery points supported by PEPFAR for HIV services that are directly providing integrated voluntary family planning services |
2015 |
221 |
FPINT_SITE |
Service delivery type: Clinical |
2015 |
221 |
FPINT_SITE |
Sum of Numerator Site Support Type disaggregates |
2015 |
221 |
FPINT_SITE |
Sum of Service Delivery Type disaggregates |
2015 |
221 |
FPINT_SITE |
Total number of PEPFAR-supported HIV service delivery points: PMTCT, Care and Treatment |
2015 |
233 |
FPINT_SITE_den |
Sum of Denominator Site Support Type disaggregates |
2015 |
221 |
LAB_ACC |
By site support type: Direct Service Delivery (DSD) |
2015 |
8 |
LAB_ACC |
Number of PEPFAR-supported testing facilities (laboratories) that are recognized by national, regional, or international standards for accreditation or have achieved a minimal acceptable level towards attainment of such accreditation |
2015 |
8 |
LAB_ACC |
Sum of Support Type disaggregates |
2015 |
8 |
LAB_CAP |
By site support type: Direct Service Delivery (DSD) |
2015 |
156 |
LAB_CAP |
Number of PEPFAR-supported testing facilities with capacity to perform clinical laboratory tests |
2015 |
156 |
LAB_CAP |
Sum of Site Support Type disaggregates |
2015 |
156 |
PMTCT_SITE |
By site support type: Direct Service Delivery (DSD): Number of PEPFAR-supported sites achieving 90% ARV or ART coverage for HIV+ pregnant women |
2015 |
210 |
PMTCT_SITE |
By site support type: Direct Service Delivery (DSD): Total number of PEPFAR supported sites providing PMTCT services (HTC and ARV or ART services) |
2015 |
233 |
PMTCT_SITE |
Number of PEPFAR-supported sites achieving 90% ARV or ART coverage for HIV+ pregnant women |
2015 |
210 |
PMTCT_SITE |
Sum of Numerator Support Type disaggregates |
2015 |
210 |
PMTCT_SITE |
Total number of PEPFAR supported sites providing PMTCT services (HTC and ARV or ART services) |
2015 |
233 |
PMTCT_SITE_den |
Sum of Denominator Support Type disaggregates |
2015 |
233 |
SITE_SUPP |
By program area/support type: Care and Support Direct Service Delivery (DSD) |
2015 |
189 |
SITE_SUPP |
By program area/support type: Food and Nutrition Technical Assistance-only (TA) |
2015 |
233 |
SITE_SUPP |
By program area/support type: General Population Prevention Technical Assistance-only (TA) |
2015 |
233 |
SITE_SUPP |
By program area/support type: HTC Direct Service Delivery (DSD) |
2015 |
233 |
SITE_SUPP |
By program area/support type: Key Populations Prevention Technical Assistance-only (TA) |
2015 |
233 |
SITE_SUPP |
By program area/support type: Lab Direct Service Delivery (DSD) |
2015 |
156 |
SITE_SUPP |
By program area/support type: PHDP/Family Planning & Integration Technical Assistance-only (TA) |
2015 |
233 |
SITE_SUPP |
By program area/support type: PMTCT Direct Service Delivery (DSD) |
2015 |
233 |
SITE_SUPP |
By program area/support type: TB/HIV Technical Assistance-only (TA) |
2015 |
233 |
SITE_SUPP |
By program area/support type: Treatment Direct Service Delivery (DSD) |
2015 |
98 |
SITE_SUPP |
By program area/support type: VMMC Direct Service Delivery (DSD) |
2015 |
48 |
TB_SCREEN |
Aggregated Age - USE WITH HQ PERMISSION ONLY: <15 |
2015 |
9,993 |
TB_SCREEN |
Aggregated Age - USE WITH HQ PERMISSION ONLY: 15+ |
2015 |
64,578 |
TB_SCREEN |
Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load |
2015 |
67,114 |
TB_SCREEN |
Sex: Female |
2015 |
48,620 |
TB_SCREEN |
Sex: Male |
2015 |
25,951 |
TB_SCREEN |
Sum of Aggregated Age disaggregates |
2015 |
74,571 |
TB_SCREEN |
Sum of Sex disaggregates |
2015 |
74,571 |
TB_SCREEN |
The number of PLHIV who were screened for TB symptoms at the last clinical visit to an HIV care facility during the reporting period |
2015 |
74,571 |
TX_CURR |
Aggregated Age/Sex: <15 Female |
2015 |
662 |
TX_CURR |
Aggregated Age/Sex: <15 Female |
2015 |
2,822 |
TX_CURR |
Aggregated Age/Sex: <15 Male |
2015 |
612 |
TX_CURR |
Aggregated Age/Sex: <15 Male |
2015 |
2,611 |
TX_CURR |
Aggregated Age/Sex: 15+ Female |
2015 |
10,146 |
TX_CURR |
Aggregated Age/Sex: 15+ Female |
2015 |
43,255 |
TX_CURR |
Aggregated Age/Sex: 15+ Male |
2015 |
5,132 |
TX_CURR |
Aggregated Age/Sex: 15+ Male |
2015 |
21,874 |
TX_CURR |
Number of adults and children receiving antiretroviral therapy (ART) |
2015 |
16,552 |
TX_CURR |
Sum of Aggregated Age/Sex <15 |
2015 |
1,274 |
TX_CURR |
Sum of Aggregated Age/Sex <15 |
2015 |
5,433 |
TX_CURR |
Sum of Aggregated Age/Sex 15+ |
2015 |
15,278 |
TX_CURR |
Sum of Aggregated Age/Sex 15+ |
2015 |
65,129 |
TX_CURR |
Sum of Aggregated Age/Sex disaggregates |
2015 |
16,552 |
TX_CURR |
Sum of Aggregated Age/Sex disaggregates |
2015 |
70,562 |
TX_CURR_NGI |
Aggregated Age/Sex: <15 Female |
2015 |
3,485 |
TX_CURR_NGI |
Aggregated Age/Sex: <15 Male |
2015 |
3,224 |
TX_CURR_NGI |
Aggregated Age/Sex: 15+ Female |
2015 |
53,400 |
TX_CURR_NGI |
Aggregated Age/Sex: 15+ Male |
2015 |
27,005 |
TX_CURR_NGI |
Sum of Aggregated Age/Sex <15 |
2015 |
6,709 |
TX_CURR_NGI |
Sum of Aggregated Age/Sex 15+ |
2015 |
80,405 |
TX_CURR_NGI |
Sum of Aggregated Age/Sex disaggregates |
2015 |
87,114 |
TX_NEW |
Aggregated Grouping by Age/Sex: <15 Female |
2015 |
1,078 |
TX_NEW |
Aggregated Grouping by Age/Sex: <15 Male |
2015 |
940 |
TX_NEW |
Aggregated Grouping by Age/Sex: 15+ Female |
2015 |
18,450 |
TX_NEW |
Aggregated Grouping by Age/Sex: 15+ Male |
2015 |
7,195 |
TX_NEW |
Number of adults and children newly enrolled on antiretroviral therapy (ART) |
2015 |
22,968 |
TX_NEW |
Sum of Aggregated Age/Sex disaggregates |
2015 |
27,663 |
TX_RET |
Age: 0-4 (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) |
2015 |
390 |
TX_RET |
Age: 15+ (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) |
2015 |
25,741 |
TX_RET |
Age: 5-14 (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) |
2015 |
1,770 |
TX_RET |
Aggregated Age: <15 (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) |
2015 |
2,160 |
TX_RET |
Aggregated Age: 15+ (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) |
2015 |
25,741 |
TX_RET |
Number of adults and children who are still alive and on treatment at 12 months after initiating ART |
2015 |
37,974 |
TX_RET |
Pregnancy and breastfeeding status (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) |
2015 |
8,767 |
TX_RET |
Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up |
2015 |
44,676 |
TX_RET_den |
Aggregated Age: <15 (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) |
2015 |
2,374 |
TX_RET_den |
Aggregated Age: 15+ (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) |
2015 |
28,287 |
VMMC_AE |
By AE Type: Number of VMMC clients with one or more moderate or severe medical device-related AE(s) |
2015 |
16 |
VMMC_AE |
By AE type: Number of VMMC clients with one or more moderate or severe surgical intra-operative AE(s) |
2015 |
3 |
VMMC_AE |
By AE Type: Number of VMMC clients with one or more moderate or severe surgical post-operative AE(s) |
2015 |
91 |
VMMC_AE |
Number of males circumcised surgically or by medical device that experienced at least one moderate or severe adverse event(s) (AEs) |
2015 |
98 |
VMMC_AE |
Sub-Disag: By Medical device-based AE(s) by maximum severity category: Number of clients with one or more moderate medical device-related AE(s), but no severe medical device-related AE(s) |
2015 |
16 |
VMMC_AE |
Sub-Disag: By Medical device-based AE(s) by maximum severity category: Number of clients with one or more severe medical device-related AE(s) |
2015 |
33 |
VMMC_AE |
Sub-Disag: By Surgical post-operative AE(s) by maximum severity category: Number of clients with one or more moderate surgical post-operative AE(s), but no severe surgical post-operative AE(s) |
2015 |
83 |
VMMC_AE |
Sub-Disag: By Surgical post-operative AE(s) by maximum severity category: Number of clients with one or more severe surgical intra-operative AE(s) |
2015 |
8 |
VMMC_AE |
Sub-Disag: Surgical intra-operative AE(s) by maximum severity category: Number of clients with one or more moderate surgical intra-operative AE(s), but no severe surgical intra-operative AE(s) |
2015 |
3 |
VMMC_AE |
Sub-Disag: Surgical intra-operative AE(s) by maximum severity category: Number of clients with one or more severe surgical intra-operative AE(s) |
2015 |
33 |
VMMC_CIRC |
By Age: 10-14 |
2015 |
5,367 |
VMMC_CIRC |
By Age: 15-19 |
2015 |
5,892 |
VMMC_CIRC |
By Age: 20-24 |
2015 |
4,938 |
VMMC_CIRC |
By Age: 25-49 |
2015 |
13,028 |
VMMC_CIRC |
By Age: 50+ |
2015 |
596 |
VMMC_CIRC |
By circumcision technique: Device-based VMMC |
2015 |
2,231 |
VMMC_CIRC |
By circumcision technique: Surgical VMMC |
2015 |
27,590 |
VMMC_CIRC |
By follow-up status: Number of surgically circumcised clients who returned at least once for follow-up care within 14 days of circumcision surgery |
2015 |
27,586 |
VMMC_CIRC |
By HIV status: Number of clients with undocumented/indeterminate HIV status or not tested for HIV at site |
2015 |
6,560 |
VMMC_CIRC |
By HIV status: Number of HIV-negative clients (tested HIV negative at VMMC program) |
2015 |
22,562 |
VMMC_CIRC |
By HIV status: Number of HIV-positive clients (tested HIV positive at VMMC site) |
2015 |
697 |
VMMC_CIRC |
Number of males circumcised as part of the voluntary medical male circumcision (VMMC) for HIV prevention program within the reporting period |
2015 |
29,821 |
VMMC_CIRC |
Sum of age disaggregates |
2015 |
29,821 |
VMMC_CIRC_NGI |
By Age: 10-14 |
2015 |
5,367 |
VMMC_CIRC_NGI |
By Age: 15-19 |
2015 |
5,892 |
VMMC_CIRC_NGI |
By Age: 20-24 |
2015 |
4,938 |
VMMC_CIRC_NGI |
By Age: 25-49 |
2015 |
13,028 |
VMMC_CIRC_NGI |
By Age: 50+ |
2015 |
596 |
VMMC_CIRC_NGI |
By circumcision technique: Device-based VMMC |
2015 |
2,234 |
VMMC_CIRC_NGI |
By circumcision technique: Surgical VMMC |
2015 |
27,587 |
VMMC_CIRC_NGI |
By follow-up status: Number of surgically circumcised clients who returned at least once for follow-up care within 14 days of circumcision surgery |
2015 |
27,586 |
VMMC_CIRC_NGI |
By HIV status: Number of clients with undocumented/indeterminate HIV status or not tested for HIV at site |
2015 |
6,560 |
VMMC_CIRC_NGI |
By HIV status: Number of HIV-negative clients (tested HIV negative at VMMC program) |
2015 |
22,562 |
VMMC_CIRC_NGI |
By HIV status: Number of HIV-positive clients (tested HIV positive at VMMC site) |
2015 |
697 |
VMMC_CIRC_NGI |
Number of males circumcised as part of the voluntary medical male circumcision (VMMC) for HIV prevention program within the reporting period |
2015 |
29,821 |
VMMC_CIRC_NGI |
Sum of Age disaggregates |
2015 |
29,821 |